NIOX Group (LON:NIOX) Shares Down 1.5% - Here's What Happened

NIOX Group Plc (LON:NIOX - Get Free Report) shares traded down 1.5% during trading on Thursday . The company traded as low as GBX 63.60 ($0.86) and last traded at GBX 64 ($0.86). 179,760 shares traded hands during trading, a decline of 85% from the average session volume of 1,235,947 shares. The stock had previously closed at GBX 65 ($0.88).

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a GBX 90 ($1.21) price target on shares of NIOX Group in a research report on Tuesday, April 15th. Berenberg Bank restated a "buy" rating and set a GBX 90 ($1.21) target price on shares of NIOX Group in a research report on Tuesday, April 15th.

NIOX Group Stock Down 1.5%

The company has a debt-to-equity ratio of 1.10, a current ratio of 6.31 and a quick ratio of 1.94. The company has a market cap of £26.29 billion, a PE ratio of 2,641.17 and a beta of 0.92. The company has a fifty day moving average price of GBX 65.04 and a 200 day moving average price of GBX 64.21.

NIOX Group (LON:NIOX - Get Free Report) last posted its quarterly earnings data on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) earnings per share (EPS) for the quarter. NIOX Group had a return on equity of 13.29% and a net margin of 28.21%. As a group, analysts anticipate that NIOX Group Plc will post 1.1658256 EPS for the current year.

Insider Activity

In related news, insider Jonathan Emms acquired 127,454 shares of the company's stock in a transaction dated Tuesday, April 1st. The stock was purchased at an average price of GBX 8 ($0.11) per share, with a total value of £10,196.32 ($13,730.57). Also, insider Ian Johnson sold 3,924,630 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of GBX 65 ($0.88), for a total transaction of £2,551,009.50 ($3,435,240.37). 46.72% of the stock is owned by corporate insiders.

NIOX Group Company Profile

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.